The health sciences industry is arguably the most heavily regulated, scrutinized and leveraged markets in the world. Participants are under increasing pressure to reduce costs while increasing the rate of development of truly innovative and beneficial products, while also increasing the return for shareholders and constituents.
Furthermore, ongoing M&A activity means that the competitive environment and landscape is constantly changing, while the need for creating value-added partnerships and alliances is blurring the lines of traditional market competitors.
Within the health sciences industry, the need for detailed research and analysis has never been stronger. The need to understand what may happen next and the reason why is increasingly important. The ability to respond with a foreknowledge of what is next can be critical to surviving in the global marketplace.
We help clients in the global pharmaceutical, biotechnology, medical devices & equipment, diagnostics, and associated products and technologies industries understand what is happening in their markets and why, and what the potential implications and recommendations are based on that information.
Over the past year KAE has:
- Completed an NPD and competitive intelligence project for a global pharmaceutical company seeking to understand likely response scenarios to an imminent launch
- Provided an international market assessment for active wound care technologies
- Conducted customer due diligence assessments on potential acquisition candidates in the medical devices market
- Detailed a competitor's sales and marketing activity and strategy for a wound care technology provider
Please browse through our Case Studies and library for other relevent material using the search tool on the right |